SOLV

NYSE Healthcare

Solventum Corporation Common Stock

Medical Instruments & Supplies

Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressings, advanced skin care, synthetic tissue matrices, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers. The Dental Solutions segment provides dental and orthodontic products, including brackets, aligners, restorative cements, and bonding agents to span the life of the tooth, and products for preventative dental care, direct and indirect restoration, and orthodontic needs. The Health Information Systems segment offers healthcare systems with software solutions comprising computer-assisted physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms. The company sells its products and services through direct-to-consumer, distribution, key account management, inside sales, and e-commerce. Solventum Corporation was incorporated in 2023 and is headquartered in Eagan, Minnesota.

๐Ÿ“Š Market Data
Price$66.63
Volume1,033,165
Market Cap11.56B
Beta0.770
RSI (14-Day)46.7
200-Day MA$73.86
50-Day MA$68.04
52-Week High$88.20
52-Week Low$62.38
P/E Ratio7.50
Forward P/E9.55
Price / Book2.29
๐ŸŽฏ Investment Strategy Scores

SOLV scores across each investment strategy. Higher is better for that strategy's goals.

๐Ÿ’ฐ Dividend Daddy 40/100โ–ฒ +1
High dividend yield + low volatility
๐Ÿš€ Moon Shot 53/100โ–ฒ +11
High growth potential (high beta + oversold)
๐Ÿ”ช Falling Knife 77/100โ–ฒ +8
Contrarian plays (oversold + below moving average)
๐ŸŽˆ Over-Hyped 28/100โ–ผ -17
Overbought stocks (potential short candidates)
Large-cap, institutional-quality stocks
๐Ÿ” Strategy Interpretation

Best fit: ๐Ÿ”ช Falling Knife (77/100) โ€” this strategy Contrarian plays (oversold + below moving average).

Lowest fit among scored strategies: ๐ŸŽˆ Over-Hyped (28/100). No single score is a buy or sell signal โ€” use multiple lenses together. Learn how to read these scores โ†’

Find SOLV in your text

Paste any article, transcript, or post โ€” the tool will extract SOLV and every other hidden ticker.

Try the Ticker Extractor โ†’

Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.
Data last updated: 2026-05-01.